With New Notification Scheme, Settlement Payout May Be Higher
AstraZeneca Pharmaceuticals has agreed to pay $103 million to settle the multidistrict litigation that claimed it and other drug companies inflated the published average wholesale prices that the government and other third-party payers use to set drug company reimbursement rates.
This premium content is locked for LawJournalNewsletters subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.